Harel Insurance Investments & Financial Services Ltd. reduces its stake in UnitedHealth Group Incorporated (NYSE:UNH)


Harel Insurance Investments & Financial Services Ltd. cut its stake in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating ) by 46.5% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 230 shares of the healthcare conglomerate’s stock after selling 200 shares during the period. The holdings of Harel Insurance Investments & Financial Services Ltd. in UnitedHealth Group were worth $117,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Signature Estate & Investment Advisors LLC boosted its stake in UnitedHealth Group by 1.2% in the first quarter. Signature Estate & Investment Advisors LLC now owns 1,606 shares of the healthcare conglomerate’s stock valued at $820,000 after buying an additional 19 shares during the period. Steph & Co. raised its stake in shares of UnitedHealth Group by 1.6% during the first quarter. Steph & Co. now owns 1,290 shares of the healthcare conglomerate’s stock valued at $658,000 after purchasing an additional 20 shares in the last quarter. Palisades Hudson Asset Management LP boosted its holdings in shares of UnitedHealth Group by 2.0% in the 4th quarter. Palisades Hudson Asset Management LP now owns 1,078 shares of the healthcare conglomerate’s stock valued at $542,000 after buying an additional 21 shares during the period. Charter Oak Capital Management LLC boosted its holdings in shares of UnitedHealth Group by 2.4% in the 4th quarter. Charter Oak Capital Management LLC now owns 881 shares of the healthcare conglomerate’s stock valued at $442,000 after buying an additional 21 shares during the period. Finally, Oxford Financial Group Ltd. raised its holdings in shares of UnitedHealth Group by 3.0% during the 4th quarter. Oxford Financial Group Ltd. now owns 720 shares of the healthcare conglomerate’s stock valued at $362,000 after purchasing an additional 21 shares during the period. Institutional investors and hedge funds own 87.48% of the company’s shares.

UnitedHealth Group pricing performance

NYSE:UNH opened at $521.41 on Monday. UnitedHealth Group Incorporated has a one year low of $383.12 and a one year high of $553.29. The company has a market cap of $489.17 billion, a P/E ratio of 27.23, a P/E/G ratio of 1.62 and a beta of 0.77. The firm’s fifty day moving average is $497.56 and its two hundred day moving average is $495.01. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.77, and a quick ratio of 0.78.

UnitedHealth Group (NYSE:UNH – Get Rating ) last posted its quarterly earnings data on Friday, July 15th. The healthcare conglomerate reported $5.57 EPS for the quarter, topping the consensus estimate of $5.24 by $0.33. The firm had revenue of $80.33 billion for the quarter, compared to the consensus estimate of $79.68 billion. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The company’s quarterly revenue was up 12.6% year over year. During the same period in the prior year, the company earned $4.70 earnings per share. equities analysts anticipate that UnitedHealth Group Incorporated will post 21.84 earnings per share for the current year.

UnitedHealth Group increases dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 28th. Shareholders of record on Monday, June 20th were given a $1.65 dividend. This represents an annualized dividend of $6.60 and a dividend yield of 1.27%. The ex-dividend date of this dividend was Thursday, June 16th. That’s a boost from UnitedHealth Group’s previous quarterly dividend of $1.45. UnitedHealth Group’s payout ratio is currently 34.46%.

Promote and demote an analyst

A number of brokerage houses opposed UNH. Truist Financial boosted their target price on shares of UnitedHealth Group from $575.00 to $610.00 in a report on Thursday, April 7th. Oppenheimer boosted their target price on shares of UnitedHealth Group from $600.00 to $610.00 and gave the stock an “outperform” rating in a research report on Monday, July 18th. SVB Leerink boosted their price objective on shares of UnitedHealth Group from $600.00 to $625.00 and gave the company an “outperform” rating in a research report on Monday, July 18th. Barclays boosted their price objective on shares of UnitedHealth Group from $495.00 to $565.00 and gave the company an “overweight” rating in a research report on Wednesday, March 30th. Finally, Royal Bank of Canada set a $563.00 target price on shares of UnitedHealth Group and gave the company an “outperform” rating in a research note on Monday, April 18th. Three analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. The company currently has a consensus rating of “Moderate Buy” and an average target price of $578.95, based on data from MarketBeat.com.

Internal activity

In other news, Director Richard T. Burke sold 2,500 shares of the business’s stock in a transaction dated Monday, May 16th. The shares were sold at an average price of $493.25, for a total value of $1,233,125.00. Following the completion of the sale, the director now owns 1,220,000 shares of the company’s stock, valued at $601,765,000. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, Director Frederick William McNabb III acquired 89 shares of the business’s stock in a transaction that occurred on Thursday, May 26th. The shares were acquired at an average price of $504.32 per share, for a total value of $44,884.48. Following the completion of the transaction, the director now directly owns 11,259 shares of the company’s stock, valued at approximately $5,678,138.88. The acquisition was disclosed in a legal filing with the Securities and Exchange Commission, which can be accessed via this link. Also, Director Richard T. Burke sold 2,500 shares of the company’s stock in a transaction dated Monday, May 16th. The shares were sold at an average price of $493.25, for a total transaction of $1,233,125.00. Following the sale, the director now directly owns 1,220,000 shares of the company’s stock, valued at approximately $601,765,000. Disclosure of this sale can be found here. Over the last 90 days, insiders have sold 17,649 shares of company stock worth $9,071,142. 0.40% of shares are owned by company insiders.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified healthcare company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses and individuals; Coverage of health care and well-being services for persons aged 50 and over, addressing their needs for preventive and emergency health services, as well as services dealing with chronic diseases and other specialist problems for older people; Medical assistance plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Selected articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Get Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)



Get UnitedHealth Group news and ratings daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Leave a Comment